fashion -WSS

fashion

author：focus 2025-09-30 16:27:01 - browse：6

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Three trends to watch in biotech in 2024

leisure time

WSS

Grail spinoff by Illumina should end disastrous merger attempt

Prime Medicine, Myeloid Therapeutics clash over genome

Why health records don't always know when patients are dead

What the US credit downgrade means for the economy, your finances

What the US credit downgrade means for the economy, your finances

Mega Millions pot grows to $1.25 billion after no winner

Wikipedia

fashion

Wikipedia

FDA approval of Sarepta Duchenne genetic therapy gives me hope

What to expect as Trump is arraigned on his Jan 6. indictment

Moonlake's readout produced a cash windfall. Risks remain

Drinking less cuts risk of oral cavity, esophageal cancer: Report

How to save PrEP access — and even expand it

‘Oppenheimer’ and the risks of AI in health care

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Medicare proposal to cover medical devices draws a mixed reaction

What the airline industry can learn from medicine

focus

Scientists inch closer to single

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Adults seen as increasingly susceptible to measles

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Carvykti CAR

CRISPR gene editing developments we’re watching in 2024

focus

leisure time

explore

focus